All News about Inozyme Pharma Inc
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
From Inozyme Pharma Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Inozyme Pharma: Q4 Earnings Insights
March 12, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
6 Analysts Have This to Say About Inozyme Pharma
September 27, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/04/09/image15_0.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/03/28/image41.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
From Inozyme Pharma Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
From Inozyme Pharma Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
Inozyme Pharma to Participate in Upcoming Investor Conferences
November 09, 2023
From Inozyme Pharma Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
From Inozyme Pharma Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/inzy.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/cdcc97c8-2c35-4216-b35a-52bb936b0c0c/small/inozyme-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's After-Market Session
September 25, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.